{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:19:34Z","timestamp":1792793974331,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172658"],"award-info":[{"award-number":["82172658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bbadis.2022.166557","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T01:07:40Z","timestamp":1663981660000},"page":"166557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment"],"prefix":"10.1016","volume":"1868","author":[{"given":"Yingze","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166557_bb0010","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2022.166557_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bbadis.2022.166557_bb0020","doi-asserted-by":"crossref","first-page":"71223","DOI":"10.18632\/oncotarget.19333","article-title":"State-of-the-art considerations in small cell lung cancer brain metastasis","volume":"8","author":"Lukas","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2022.166557_bb0025","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/cancers13040820","article-title":"Pathology and classification of SCLC","volume":"13","author":"Raso","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2022.166557_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.thorsurg.2021.05.005","article-title":"Neuroendocrine tumors of the lung","volume":"31","author":"Randhawa","year":"2021","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.bbadis.2022.166557_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.path.2019.10.002","article-title":"Pulmonary neuroendocrine tumors","volume":"13","author":"Borczuk","year":"2020","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.bbadis.2022.166557_bb0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jtho.2020.11.006","article-title":"YAP1 expression in SCLC defines a distinct subtype with t-cell-inflamed phenotype","volume":"16","author":"Owonikoko","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000591","article-title":"Yap suppresses T-cell function and infiltration in the tumor microenvironment","volume":"18","author":"Stampouloglou","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell."},{"key":"10.1016\/j.bbadis.2022.166557_bb0060","series-title":"Interational Association for the Study of Lung Cancer World Conference on Lung Cancer (Barcelona, Spain)","article-title":"ASCL1, NEUROD1, and POU2F3 drive distinct subtypes of small cell lung cancer with unique therapeutic vulnerabilities","author":"Gay","year":"2019"},{"key":"10.1016\/j.bbadis.2022.166557_bb0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2022.166557_bb0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","article-title":"Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.chest.2018.07.029","article-title":"Characteristics and outcomes of small cell lung cancer detected by ct screening","volume":"154","author":"Thomas","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.bbadis.2022.166557_bb0080","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO executive board, ESMO guidelines committee, EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.annonc.2021.02.025","article-title":"Small cell lung cancer: a slightly less orphan disease after immunotherapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0090","article-title":"Nonlinear elasticity of biological basement membrane revealed by rapid inflation and deflation","volume":"118","author":"Li","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2022.166557_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.12.020","article-title":"Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer","volume":"1","author":"Jiang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2022.166557_bb0100","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1042\/BSR20192732","article-title":"Multifunctional neuron-specific enolase: its role in lung diseases","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbadis.2022.166557_bb0105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101039","article-title":"Neuron specific enolase promotes tumor metastasis by activating the Wnt\/\u03b2-catenin pathway in small cell lung cancer","volume":"14","author":"Zha","year":"2021","journal-title":"Trans. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/COC.0000000000000867","article-title":"Treatment and prevention of brain metastases in small cell lung cancer","volume":"44","author":"Rittberg","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0120","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.celrep.2019.05.057","article-title":"Tumor heterogeneity underlies differential cisplatin sensitivity in mouse models of small-cell lung cancer","volume":"27","author":"B\u00f6ttger","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2022.166557_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166557_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166557_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166557_bb0140","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.aav0173","article-title":"Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation","volume":"363","author":"Lee","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2022.166557_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/d41586-020-02383-5","article-title":"Cancer cells stock up in lymph vessels to survive","volume":"585","author":"Gr\u00fcner","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166557_bb0150","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.aal3622","article-title":"Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice","volume":"359","author":"Pereira","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2022.166557_bb0155","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/annonc\/mdz122","article-title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","volume":"30","author":"Tay","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtho.2019.10.007","article-title":"Profiling of circulating free dna using targeted and genome-wide sequencing in patients with SCLC","volume":"15","author":"Mohan","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semcdb.2016.09.007","article-title":"Physiological and pathological functions of neuroserpin: regulation of cellular responses through multiple mechanisms","volume":"62","author":"Lee","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166557_bb0175","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1177\/0271678X20951995","article-title":"Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity","volume":"40","author":"Ronaldson","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2022.166557_bb0180","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41571-021-00529-6","article-title":"The blood-tumour barrier in cancer biology and therapy","volume":"18","author":"Steeg","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell."},{"key":"10.1016\/j.bbadis.2022.166557_bb0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.redox.2018.01.003","article-title":"2-chlorohexadecanoic acid induces ER stress and mitochondrial dysfunction in brain microvascular endothelial cells","volume":"15","author":"Bernhart","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0195","article-title":"Vascular inflammation is a risk factor associated with brain atrophy and disease severity in Parkinson's disease: a case-control study","volume":"14","author":"Yu","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2022.166557_bb0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2014.03.002","article-title":"Interleukin-1\u03b2 induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model","volume":"15","author":"Labus","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbadis.2022.166557_bb0205","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.21037\/tlcr-21-356","article-title":"Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1","volume":"10","author":"Mao","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bbadis.2022.166557_bb0210","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.bbadis.2022.166557_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.1609828","article-title":"The adipokine component in the molecular regulation of cancer cell survival, proliferation and metastasis","volume":"27","author":"Umar","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbadis.2022.166557_bb0220","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1096\/fj.201800428R","article-title":"Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain","volume":"33","author":"Xu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2022.166557_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1566524018666181109121849","article-title":"Role of HIF-1 in cancer progression: novel insights. A review","volume":"18","author":"Pezzuto","year":"2018","journal-title":"Curr. Mol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-016-0399-7","article-title":"Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways","volume":"35","author":"Wan","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1989","key":"10.1016\/j.bbadis.2022.166557_bb0235","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1889","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbadis.2022.166557_bb0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0245","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat. Rev. Cancer Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0250","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.bbadis.2022.166557_bb0255","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/d41586-018-04161-w","article-title":"Cancer research with a human touch","volume":"556","author":"May","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166557_bb0265","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.7384789","article-title":"Therapy of spontaneous metastasis by intravenous injection of liposomes containing lymphokines","volume":"208","author":"Fidler","year":"1980","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbadis.2022.166557_bb0270","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.gastro.2018.10.054","article-title":"Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by competitively binding GMAN-AS","volume":"156","author":"Zhuo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2022.166557_bb0275","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2020.12.030","article-title":"A mouse model for microbeam radiation therapy of the lung","volume":"110","author":"Sch\u00fcltke","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbadis.2022.166557_bb0280","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","article-title":"Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer","volume":"20","author":"Hodgkinson","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0285","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/2159-8290.CD-17-0935","article-title":"Genomic and functional Fidelity of small cell lung cancer patient-derived xenografts","volume":"8","author":"Drapkin","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2022.166557_bb0290","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.lungcan.2018.11.014","article-title":"Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis","volume":"126","author":"Udagawa","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0295","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41467-022-29794-4","article-title":"Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts","volume":"13","author":"Caeser","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2022.166557_bb0300","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s43018-019-0020-z","article-title":"Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer","volume":"1","author":"Stewart","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0305","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1038\/ncomms13322","article-title":"Vasculogenic mimicry in small cell lung cancer","volume":"7","author":"Williamson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2022.166557_bb0310","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.abc1944","article-title":"Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts","volume":"371","author":"Quinn","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2022.166557_bb0315","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/2159-8290.CD-17-0935","article-title":"Genomic and functional fidelity of small cell lung cancer patient-derived xenografts","volume":"8","author":"Drapkin","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2022.166557_bb0320","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI81603","article-title":"CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer","volume":"126","author":"Weiskopf","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2022.166557_bb0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","article-title":"Applications of patient-derived tumor xenograft models and tumor organoids","volume":"13","author":"Yoshida","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0330","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00401-017-1757-z","article-title":"RNAi screen identifies essential regulators of human brain metastasis-initiating cells","volume":"134","author":"Singh","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0335","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.7150\/thno.33680","article-title":"CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter","volume":"9","author":"Qiu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2022.166557_bb0340","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.12.002","article-title":"Brain metastasis models: what should we aim to achieve better treatments?","volume":"169","author":"Masmudi-Mart\u00edn","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbadis.2022.166557_bb0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1535-6108(03)00220-4","article-title":"Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model","volume":"4","author":"Meuwissen","year":"2003","journal-title":"Cancer cell."},{"key":"10.1016\/j.bbadis.2022.166557_bb0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","article-title":"MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition","volume":"31","author":"Mollaoglu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0355","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-0385","article-title":"Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition","volume":"8","author":"Jia","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2022.166557_bb0360","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2014.02.031","article-title":"Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing","volume":"156","author":"McFadden","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccell.2020.04.016","article-title":"MAX functions as a tumor suppressor and rewires metabolism in small cell lung cancer","volume":"38","author":"Augert","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc3001","article-title":"Mouse models of advanced spontaneous metastasis for experimental therapeutics","volume":"11","author":"Francia","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0375","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/2159-8290.CD-17-0987","article-title":"Intertumoral heterogeneity in SCLC is influenced by the cell type of origin","volume":"8","author":"Yang","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2022.166557_bb0380","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nprot.2017.137","article-title":"A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression","volume":"13","author":"Fumagalli","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2022.166557_bb0385","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","article-title":"An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping","volume":"183","author":"Kawasaki","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0390","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1111\/jcmm.13722","article-title":"Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: a single-center experience in China","volume":"22","author":"Wu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0395","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?","volume":"96","author":"Bellizzi","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0400","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cca.2020.06.037","article-title":"Selective application of neuroendocrine markers in the diagnosis and treatment of small cell lung cancer","volume":"509","author":"Du","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2022.166557_bb0405","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/ol.2020.12164","article-title":"Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy","volume":"20","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2022.166557_bb0410","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"19","author":"Ganti","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.bbadis.2022.166557_bb0415","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1038\/s41598-021-88030-z","article-title":"Buprenorphine alters microglia and astrocytes acutely following diffuse traumatic brain injury","volume":"11","author":"Ryu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2022.166557_bb0420","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12035-021-02600-w","article-title":"Generation and release of neurogranin, vimentin, and mbp proteolytic peptides, following traumatic brain injury","volume":"59","author":"Sarkis","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0425","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/neuonc\/noaa232","article-title":"Brain metastasis detection using machine learning: a systematic review and meta-analysis","volume":"23","author":"Cho","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2022.166557_bb0430","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40644-021-00410-w","article-title":"Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.bbadis.2022.166557_bb0435","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0440","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","article-title":"Whole-brain radiotherapy for brain metastases: evolution or revolution?","volume":"36","author":"Brown","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0445","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers14040879","article-title":"What does PET imaging bring to neuro-oncology in 2022?","volume":"14","author":"Zhang-Yin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2022.166557_bb0450","doi-asserted-by":"crossref","first-page":"S1164","DOI":"10.1016\/j.annonc.2021.08.234","article-title":"1650P - adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting","volume":"32","author":"Tsui","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0455","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.21.01639","article-title":"Radiation and systemic therapy for limited-stage small-cell lung cancer","volume":"40","author":"Bogart","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0460","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"EORTC radiation oncology group and lung cancer group, prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0465","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.6004\/jnccn.2021.7105","article-title":"Role of prophylactic cranial irradiation in extensive-stage small cell lung cancer","volume":"19","author":"Yu","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.bbadis.2022.166557_bb0470","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.6004\/jnccn.2018.0079","article-title":"NCCN guidelines insights: small cell lung cancer, version 2.2018","volume":"16","author":"Kalemkerian","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.bbadis.2022.166557_bb0475","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jtho.2021.03.015","article-title":"Why did the randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC not reveal a Difference?","volume":"16","author":"Belderbos","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0480","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase iii trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0485","series-title":"Outcome und Prognosefaktoren bei singul\u00e4ren Hirnmetastasen des kleinzelligen Bronchialkarzinoms. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft","first-page":"98","article-title":"Outcome and prognostic factors in single brain metastases from small-cell lung cancer","volume":"194","author":"Bernhardt","year":"2018"},{"key":"10.1016\/j.bbadis.2022.166557_bb0490","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0495","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.20.00747","article-title":"Hippocampal avoidance and memantine for whole-brain radiotherapy: long-term follow-up warranted","volume":"38","author":"Andratschke","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0500","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2019.00205","article-title":"Whole brain radiation therapy plus stereotactic radiosurgery in the treatment of brain metastasis leading to improved survival in patients with favorable prognostic factors","volume":"9","author":"Khan","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0510","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0515","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","article-title":"Japan clinical oncology group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer","volume":"346","author":"Noda","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0520","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3816\/CLC.2008.n.006","article-title":"Chemotherapy for brain metastases in small-cell lung cancer","volume":"9","author":"Chen","year":"2008","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0525","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.18632\/oncotarget.23616","article-title":"Targeted drugs for systemic therapy of lung cancer with brain metastases","volume":"9","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2022.166557_bb0530","first-page":"1707","article-title":"The efficacy and safety of irinotecan combined with nedaplatin in the treatment of small cell lung cancer","author":"Fu","year":"2020","journal-title":"J. BUON."},{"key":"10.1016\/j.bbadis.2022.166557_bb0535","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/S0959-8049(02)00140-5","article-title":"Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. A multicentre phase II study","volume":"38","author":"Korfel","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0540","first-page":"79","article-title":"Comparative assessment of three different second-line regimens in chemotherapy resistant \/ refractory small-cell lung cancer","volume":"26","author":"Hacibekiroglu","year":"2021","journal-title":"J. BUON."},{"key":"10.1016\/j.bbadis.2022.166557_bb0545","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1200\/JCO.1992.10.8.1230","article-title":"Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a cancer and leukemia group B pilot study","volume":"10","author":"Aisner","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0550","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1002\/cam4.1616","article-title":"Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer","volume":"7","author":"Zhao","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0555","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12885-018-4715-9","article-title":"Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: a meta-analysis","volume":"18","author":"Xu","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0560","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejca.2022.03.034","article-title":"Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer","volume":"169","author":"Park","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0565","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijrobp.2020.06.008","article-title":"Is there a role for hypofractionated thoracic radiation therapy in limited-stage small cell lung cancer? A propensity score matched analysis","volume":"108","author":"Zayed","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbadis.2022.166557_bb0570","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.3390\/curroncol28050347","article-title":"Immunotherapy in extensive-stage small cell lung cancer","volume":"28","author":"Sayed","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188615","article-title":"Advances in clinical immunotherapy for gastric cancer","volume":"1876","author":"Li","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0580","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ccell.2018.04.001","article-title":"Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.bbadis.2022.166557_bb0585","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jtho.2019.05.042","article-title":"Improved prognosis and increased tumor-infiltrating lymphocytes in patients who have SCLC with neurologic paraneoplastic syndromes","volume":"14","author":"Iams","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0590","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11060-016-2216-8","article-title":"Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)","volume":"130","author":"Berghoff","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0595","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.2017.76.6212","article-title":"CheckMate-032 study: efficacy and safety of nivolumab and nivolumab plus ipilimumab in patients with metastatic esophagogastric cancer","volume":"36","author":"Janjigian","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0600","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.7150\/jca.31755","article-title":"Changes in expression of multiple checkpoint molecules and infiltration of tumor immune cells after neoadjuvant chemotherapy in gastric cancer","volume":"10","author":"Yu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0605","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jtho.2018.10.003","article-title":"Third-line nivolumab monotherapy in recurrent SCLC: CheckMate 032","volume":"14","author":"Ready","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0610","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.annonc.2020.11.018","article-title":"Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy","volume":"32","author":"Sznol","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0615","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1200\/JCO.2016.67.6601","article-title":"Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer","volume":"34","author":"Reck","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0620","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ccell.2018.04.001","article-title":"Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2022.166557_bb0625","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"IMpower133 study group. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2022.166557_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00008-5","article-title":"Combination treatment options for small-cell lung cancer","volume":"22","author":"Horita","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0635","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.20.00793","article-title":"KEYNOTE-604 investigators, pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study","volume":"38","author":"Rudin","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0640","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2008.20.1061","article-title":"Phase III trial of irinotecan\/cisplatin compared with etoposide\/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124","volume":"27","author":"Lara","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0645","series-title":"Randomized Phase II Clinical Trial of Cisplatin\/carboplatin and Etoposide (CE) Alone or in Combination With Nivolumab as Frontline Therapy for Extensive-stage Small Cell Lung Cancer (ES-SCLC): ECOG-ACRIN EA5161","author":"Leal","year":"2020"},{"key":"10.1016\/j.bbadis.2022.166557_bb0650","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1200\/JCO.2010.29.3423","article-title":"Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial","volume":"29","author":"Spigel","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0655","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cllc.2014.09.001","volume":"16","author":"Tiseo","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb0660","article-title":"Impact of brain metastases on treatment patterns and outcomes with first-line durvalumab plus platinum-etoposide in extensive-stage SCLC (CASPIAN): a brief report","volume":"3","author":"Chen","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.bbadis.2022.166557_bb0665","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"CASPIAN investigators, durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbadis.2022.166557_bb0670","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3389\/fimmu.2019.01321","article-title":"L-selectin enhanced T cells improve the efficacy of cancer immunotherapy","volume":"10","author":"Watson","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0675","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(18)30254-7","article-title":"MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Dreno","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0680","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00262-018-2287-9","article-title":"Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer","volume":"68","author":"Chiappori","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbadis.2022.166557_bb0685","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2022.166557_bb0690","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbadis.2022.166557_bb0695","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3390\/cancers12123629","article-title":"Systematic review and network meta-analysis of immune checkpoint inhibitors in combination with chemotherapy as a first-line therapy for extensive-stage small cell carcinoma","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2022.166557_bb9000","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3892\/or.2015.4204","article-title":"Radiosensitization of non-small cell lung cancer by kaempferol","volume":"34","author":"Kuo","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2022.166557_bb9005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/biomedicines9010048","article-title":"Current status and future perspectives of liquid biopsy in small cell ung cancer","volume":"9","author":"Mondelo-Mac\u00eda","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbadis.2022.166557_bb9010","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.0808698106","article-title":"VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown","volume":"106","author":"Argaw","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bbadis.2022.166557_bb9015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040787","article-title":"Novel RNAi-mediated approach to G protein-coupled receptor deorphanization: proof of principle and characterization of a planarian 5-HT receptor","volume":"7","author":"Zamanian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2022.166557_bb9020","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103973","article-title":"Up-regulation of brain cytokines and metalloproteinases 1 and 2 contributes to neurological deficit and brain damage in transient ischemic stroke","volume":"129","author":"Victoria","year":"2020","journal-title":"Microvasc.Res."},{"key":"10.1016\/j.bbadis.2022.166557_bb9025","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.26031","article-title":"The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs","volume":"128","author":"Langley","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2022.166557_bb9030","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.750726","article-title":"Exendin-4 preserves blood-brain barrier integrity via glucagon-like peptide 1 receptor\/activated protein kinase-dependent nuclear factor-kappa B\/matrix metalloproteinase-9 inhibition after subarachnoid hemorrhage in rat","volume":"14","author":"Xie","year":"2021","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166557_bb9035","first-page":"118","article-title":"A simple bioluminescence imaging method for studying cancer cell growth and metastasis after subcutaneous injection of Lewis lung carcinoma cells in syngeneic C57BL\/6 mice","volume":"5","author":"Zhu","year":"2018","journal-title":"React. Oxyg. Species (Apex)"},{"key":"10.1016\/j.bbadis.2022.166557_bb9040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00292-017-0346-1","article-title":"Etablierung einer Living Biobank : Bessere Steuerung der Pr\u00e4zisionsonkologie durch In-vitro- und In-vivo-Krebsmodelle, Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models","volume":"38","author":"Pauli","year":"2017","journal-title":"Pathologe"},{"key":"10.1016\/j.bbadis.2022.166557_bb9045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40425-019-0518-z","article-title":"Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts","volume":"7","author":"Capasso","year":"2019","journal-title":"J. Immunother. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922002289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922002289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:46:48Z","timestamp":1778770008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922002289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":148,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0925443922002289"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166557","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166557"}}